Prosecution Insights
Last updated: April 19, 2026

Atai Therapeutics, Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18526500 CRYSTALLINE FORMS OF N,N-DIMETHYLTRYPTAMINE AND METHODS OF USING THE SAME HABTE, KAHSAY 1624 Non-Final OA Dec 01, 2023
18504056 SYSTEMS, DEVICES, AND METHODS FOR EVENT-BASED KNOWLEDGE REASONING SYSTEMS USING ACTIVE AND PASSIVE SENSORS FOR PATIENT MONITORING AND FEEDBACK BURGESS, JOSEPH D 3685 Non-Final OA Nov 07, 2023
18462120 HETEROATOM SUBSTITUTED CYCLIC AND ALKYL AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS PATEL, SAGAR S 1626 Non-Final OA Sep 06, 2023

Managing Atai Therapeutics, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month